Regal Healthcare Capital Partners has announced the close of its fourth private equity fund.

The fund — RHCP IV — closed at $610 million of total commitments and closed above its original target of $550 million.

Regal, founded in 2018 and based in New York, is a control growth equity and buyout firm focused exclusively on lower middle market healthcare services companies. The firm targets multi-site and/or provider-led businesses with revenue between $20 million and $100 million and EBITDA between $2 million and $10 million.

Altaris has announced it will acquire the Life Sciences & Healthcare business (LS&H) from Clarivate (NYSE: CLVT) for $600 million.

LS&H is comprised of the Cortellis and Decision Resources Group portfolios. LS&H is an AI-enabled data intelligence products and services business supporting R&D and commercialization decisions for pharmaceutical, biotechnology and medical technology companies. 

Altaris, founded in 2002 and based in New York, seeks control and minority equity investments exclusively in healthcare. The firm targets companies within the life sciences/pharmaceutical, provider services and non-reimbursement healthcare industries. Altaris is flexible in its investment sizes.

Following completion of the transaction, which is expected to close in the second half of 2026, LS&H will operate as an independent company.

Amanda Blank, CEO of Founders Beauty Group, joins McGuireWoods partner and host Geoff Cockrell to discuss the growth of her strategic med spa platform, built on a hub-and-spoke model across four geographies through the acquisition of established, doctor-owned, cash-pay practices.

Amanda shares how she evaluated different capital sources during the company’s growth, including her decision to partner with high-net-worth family offices rather than private equity investors at that stage of the business, and discusses the factors that informed that approach.

She also explores why specialized industry knowledge matters for investors in the med spa sector, why GLP-1s are unlikely to serve as an anchor service, where durable competitive advantages exist in a relatively low-barrier market and how her experience leading a woman-owned platform has shaped the company’s growth.

An affiliate of Peak Rock Capital has acquired Asembia, according to a news release.

Asembia, founded in 2005 and based in Florham Park, New Jersey, is a provider of technology enabled commercialization solutions for specialty pharma to pharmaceutical manufacturers, pharmacies, patients and prescribers. 

Peak Rock, founded in 2012 and based in Austin, Texas, is middle market private equity firm that pursues a wide range of investments. The firm targets companies in healthcare and a few other industries operating in North America and Europe. Peak Rock seeks to invest $30 million to $500 million in companies with enterprise values of $50 million to $1.5 billion.

Terms of the acquisition were not disclosed.

Martis Capital has announced it has acquired a majority stake in Deerfield Group.

Deerfield Group, founded in 2013 and based in Conshohocken, Pennsylvania, is a marketing, communications and media partner for the healthcare and life sciences sectors.

Martis Capital, founded in 2011 and with offices in San Francisco, Miami, and Washington, D.C., is a private equity firm focused exclusively on the healthcare industry. The firm considers a broad range of buyout and growth equity opportunities in middle market North American healthcare companies with $1 million to $250 million in total enterprise value.

Terms of the acquisition were not disclosed.

The provider services M&A market is probably approaching 50% of peak deal volume — well below historical norms — yet J. Kyle Brown sees real momentum building. Kyle is managing director and lead of the provider services group at Brown Gibbons Lang & Company.

In this conversation with McGuireWoods partner and host Geoff Cockrell, Kyle unpacks how, after holding over a hundred private equity provider services assets for six years, demand finally feels different — the first real shift since early 2023.

They examine the evolution from TopCo MSO equity to near-term incentive structures and discuss which subsectors — ASCs, infusion, ENT and interventional pain — are drawing the most investor attention. 

TELEO Capital Management has announced it has acquired SmartFactory Rx from Applied Materials.

SmartFactory Rx is a pharmaceutical manufacturing intelligence platform.

TELEO, founded in 2018 and based in Boise, Idaho, is a private equity firm targeting opportunities in healthcare IT, software and technology, business services and industrial sectors. The firm prefers to invest $10 million to $30 million per platform in companies with $10 million to $100 million in revenue.

Applied Materials (NASDAQ: AMAT), founded in 1967 and based in Santa Clara, California, is a global supplier of semiconductor manufacturing equipment.

Terms of the transaction were not disclosed. SmartFactory has been rebranded as Modersys as part of the transaction.

In this episode of the Becker Private Equity & Business Podcast, Amber Walsh, Partner at McGuireWoods, discusses how AI is reshaping the legal and healthcare industries, the leadership skills organizations need to navigate rapid change, and why clear communication and decisive action are critical for long-term success.

In this episode of the Becker Private Equity & Business Podcast, Holly Buckley, chair of the McGuireWoods’ healthcare department, discusses the current state of the healthcare private equity market, why alignment is critical to closing successful deals, and how leadership, culture, and AI adoption are shaping organizations built to last.

Incline Equity Partners has announced an investment in West Physics.

West Physics, founded in 2002 and based in Atlanta, is a provider of medical and health physics testing and consulting services.

Incline, founded in 2011 and based in Pittsburgh, Pennsylvania, .is a private equity firm that invests across the middle market in services, value-added distribution, software and technology, and specialized light manufacturing companies. The firm generally pursues buyouts, corporate divestitures and minority recapitalizations in U.S. and Canadian companies with enterprise values of $25 million to $750 million.

Terms of the investment were not disclosed.